Franz DN, Lawson J, Yapici Z, et al. Long-term efficacy and safety of everolimus as adjuctive therapy in patients with tuberous sclerosis complex (TSC)-associated treatment -refractory seizures: Final analysis of the EXIST-3 study. EAN 2018, abstract O424.,Franz DN, Lawson JA, Yapici Z, et al. Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures. Epilepsia. 2018;59:1188-97.
Onderzoek naar therapieresistentie bij kanker krijgt forse financiële impuls
nov 2021 | Borstkanker, Bot en wekedelentumoren, Dermato-oncologie, Gynaecologische oncologie, Hoofd-halsoncologie, Immuuntherapie, Longoncologie, Maag-darm-leveroncologie, Mesothelioom, Neuro-oncologie, Uro-oncologie